Reuters logo
BRIEF-Protagonist Therapeutics Q3 ‍net loss per share $0.29​
November 6, 2017 / 9:47 PM / in 12 days

BRIEF-Protagonist Therapeutics Q3 ‍net loss per share $0.29​

Nov 6 (Reuters) - Protagonist Therapeutics Inc

* Protagonist Therapeutics reports third quarter 2017 financial results and provides corporate update

* Protagonist Therapeutics Inc qtrly ‍net loss per share attributable to common stockholders was $0.29​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below